MustGrow Biologics (FRA:0C0) Beginning Cash Position: €0.26 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0C0 MustGrow Biologics Corp FRA:0C0
28 GF Score
Price €0.25
GF Value €0.50
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is MustGrow Biologics Beginning Cash Position?

MustGrow Biologics FRA:0C0 -8.03% 28 Beginning Cash Position is €0.26 Mil as of Jun. 2026. GuruFocus rates FRA:0C0 with a GF Score™ of 28/100 and a GF Value™ of €0.50 (Possible Value Trap). The stock has 3 warning signs investors should review.

MustGrow Biologics's Beginning Cash Position for the quarter that ended in Jun. 2026 was €0.26 Mil.

MustGrow Biologics's quarterly Beginning Cash Position declined from Dec. 2025 (€1.11 Mil) to Mar. 2026 (€0.58 Mil) and declined from Mar. 2026 (€0.58 Mil) to Jun. 2026 (€0.26 Mil).

MustGrow Biologics's annual Beginning Cash Position declined from Dec. 2023 (€4.80 Mil) to Dec. 2024 (€4.57 Mil) and declined from Dec. 2024 (€4.57 Mil) to Dec. 2025 (€0.93 Mil).

MustGrow Biologics Beginning Cash Position Related Terms

MustGrow Biologics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for MustGrow Biologics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MustGrow Biologics Beginning Cash Position Chart

MustGrow Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.29 6.69 4.80 4.57 0.93

MustGrow Biologics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.12 1.11 0.58 0.26
FRA:0C0
28GF Score
MustGrow Biologics Corp FRA:0C0
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MustGrow Biologics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €0.26 Mil mean?
MustGrow Biologics (FRA:0C0) has a Beginning Cash Position of €0.26 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on MustGrow Biologics and its competitors.
Is MustGrow Biologics' Beginning Cash Position too high?
MustGrow Biologics' current Beginning Cash Position is €0.26 Mil. Overall, MustGrow Biologics has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Beginning Cash Position compare to CTVA and CF?
MustGrow Biologics' Beginning Cash Position of €0.26 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for an Agriculture company?
A good Beginning Cash Position depends on the Agriculture industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on MustGrow Biologics and its competitors. MustGrow Biologics's current Beginning Cash Position is €0.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
Based on GuruFocus' analysis, MustGrow Biologics (FRA:0C0) is currently considered Possible Value Trap. The stock's GF Value™ is €0.50, compared to a current price of €0.25 — trading 49.6% below its estimated fair value. The current Beginning Cash Position is €0.26 Mil. MustGrow Biologics' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For MustGrow Biologics (FRA:0C0), the current Beginning Cash Position is €0.26 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MustGrow Biologics (FRA:0C0) Overvalued in 2026?

Based on GuruFocus' analysis, MustGrow Biologics stock appears to be undervalued. The current stock price of €0.25 is trading 49.6% below its estimated GF Value™ of €0.50. GuruFocus considers MustGrow Biologics to be Possible Value Trap.

Key valuation signals for FRA:0C0:

  • Beginning Cash Position: €0.26 Mil
  • GF Value™: €0.50 vs. price of €0.25 (49.6% below fair value)
  • GF Score™: 28/100 with 3 warning signs

No single metric tells the full story. See the FRA:0C0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MustGrow Biologics Business Description

Other Exchanges MGROF:USAMGRO:Canada
Address 1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
28GF Score

Get the complete analysis for FRA:0C0

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.25
Price
€0.50
GF Value